Systematic Reviews
Copyright ©The Author(s) 2025.
World J Gastrointest Oncol. Jul 15, 2025; 17(7): 106701
Published online Jul 15, 2025. doi: 10.4251/wjgo.v17.i7.106701
Table 5 Tumor genetic features
Genetic features
Ref.
11p.15.5 mutation[29]
13q14.2 (RB1)[40]
6p22[40]
9p21 (CDKN2A/B) mutation[29,40]
APC mutationCase from this study[6,8,12,14,29,40]
B72.3[17,43]
BCL10[12,28,29,42,49]
CDKN2A loss (chr 9p)[6]
CTNNB1 mutation[6,28,40,42,50,54]
cyclin D1[37]
DDR2[37]
EWSR1-FLI1 fusion[6]
FANCD2[37]
FGF3[6]
FGF4[6]
FGFR1 c1081+1G>T (somatic)[6]
FGFR2[37]
FGFR20INA fusion[6]
INSM1[28,29,52]
KMT2C[37]
LAMP1[37]
MEN1 mutation[28]
MLH1[52]
MLH6[52]
MSH2[52]
NSD3/WHSc1 L1 mutations[40]
NSE[7,40]
PIK3CA mutation[29]
PMS2[52]
RB1 Loss of exons18-27[39]
SMAD4 (DPC4) mutation[28,29]
SMARCA4[28]
SMARCB1[28]
SSTR2 mutation[31]
Wnt/beta-catenin pathway mutation[6,7,12,29,37,40,41,43]